Fall 2025 COVID Vaccine Information

COVID cases are widespread currently.  You can reduce your risk by avoiding crowded gatherings, using azelastine nasal spray as a preventative, or doing a sinus-rinse kit to reduce your risk of infection after being out in public.

We do recommend receiving this year's COVID booster. As previously mentioned, we recommend either the non-mRNA option called Nuvaxovid (previously Novavax) or the new vaccine by Moderna called mNEXSPIKE. The decision is up to each patient's preference - keep reading for more information on the two. 

Nuvaxovid is the traditionally made, non-mRNA COVID vaccine. We recommend this option since its immunity is thought to last longer than the mRNA vaccines, and it causes fewer and milder side effects in the first 48 hours. Ladue should be receiving a small stock of Nuvaxovid today. Barring any delivery issues, they will have this available at the clinics this week. 

For those who would like to stick with Moderna, we also recommend mNEXSPIKE over Spikevax as it has been found to be more effective than Spikevax. Additionally, since mNEXSPIKE targets specific parts of the spike protein rather than the whole protein, it requires a smaller mRNA dose.